Why is Dr Reddy's Labs falling/rising?

As of 08-Aug, Dr Reddy's Laboratories Ltd is experiencing a price increase, with the current price at 1,215.00, reflecting a rise of 14.25 or 1.19%. The stock has shown a positive performance today, outperforming its sector by 2.35% and has gained consecutively over the last two days, yielding a total return of 1.5% during this period. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a potential struggle in maintaining upward momentum. Additionally, there has been a decline in investor participation, with delivery volume falling by 10.21% against the 5-day average. Despite these challenges, the company is characterized by strong long-term fundamentals, including low debt levels, healthy net sales growth, and a solid return on equity, which may contribute to investor confidence.
In the broader market context, Dr Reddy's stock has underperformed relative to the benchmark, with a year-to-date decline of 12.48% compared to a 2.20% increase in the Sensex. Over the past week, the stock has decreased by 0.38%, while the Sensex has fallen by 0.92%. This underperformance highlights the stock's challenges in the current market environment, despite its attractive valuation and high institutional holdings at 63.1%. The company's ability to generate profits has been positive, but the overall market sentiment and recent flat results may be weighing on its stock performance.